Exelixis
EXEL
#1622
Rank
$10.36 B
Marketcap
$37.04
Share price
1.79%
Change (1 day)
58.70%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company